About Us
G-NiiB GenieBiome, a biotechnology spinout from The Chinese University of Hong Kong was founded by world-renowned clinician-scientists and supported by a multidisciplinary team of experts in microbiology, metagenomics, bioinformatics, disease biomarkers, food technology, clinical trials, IP development and commercialization. For over a decade, our team has pioneered the use of microbiome with evidence-based science to tackle a myriad of diseases, including novel virus, gut serious illness, overweight and metabolic syndrome, skin irritation and mental health.
Our precision portfolio of G-NiiB GenieBiome includes diagnostic and risk prediction tests, next-generation microbiome precision formula, and precision medicine tailored for the Asian population.
Microbiome offers infinite possibilities to human health. We create a unique solution for early disease detection, prevention and personalized treatment to bring health to mankind.
To be a game changer in human health with microbiome solutions.
To transform novel microbiome discoveries into effective diagnostics and therapeutics.
Our passion is to bring health to Generation-Next with Innovation and Integrity in microBiome development.
